2 insiders bought €33k of shares over the last 90 days, the latest filed 05 Aug 2026.
Camp4 Therapeutics Corp is a listed company. Its directors and officers file their transactions with SEC (Form 4). Between 18 October 2025 and 18 October 2026, 5 insiders published 9 filings.
Open-market activity splits into 2 purchases totalling €33k and 6 sales totalling €2.1M; 2 insiders sit on the buying side and 2 insiders on the selling side. Netting one side against the other leaves €2.1M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. At €1.4M, the sale published on 31 August 2026 by Schwab Andrew J. is the largest of the period (0.68% of market cap). The buyers include 1 senior executive and 1 chief executive.
The data flag 2 purchases as part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. The last purchase on record was published on 5 August 2026, which is 73 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Across the 5,458 companies tracked on its exchange, the median is 22 filings; at 9 filings, this issuer sits below that mark. Since 2024, the database holds 7 purchases and 6 sales by insiders of the company.
In the same market, recent insider purchases at GameStop Corp. and Heico Corp also feature in our signals. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
+1 other insider
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Camp4 Therapeutics Corp Strong Buy (bullish), based on 8 analysts. Average price target: US$10.25.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
Same trade as the filing by Polaris Management Co. VII, L.L.C., counted once · View ↗
25 of 32 declarations
Camp4 Therapeutics Corp is a company focused on developing innovative therapies for genetic diseases. It employs genome editing approaches to create therapeutic solutions.
Purchases our model currently ranks for the recommendations list.
All recommendations